======= RANBP3 ======= == Gene Information == * **Official Symbol**: RANBP3 * **Official Name**: RAN binding protein 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8498|8498]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H6Z4|Q9H6Z4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RANBP3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RANBP3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603327|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a cofactor for XPO1/CRM1-mediated nuclear export, perhaps as export complex scaffolding protein. Bound to XPO1/CRM1, stabilizes the XPO1/CRM1-cargo interaction. In the absence of Ran-bound GTP prevents binding of XPO1/CRM1 to the nuclear pore complex. Binds to CHC1/RCC1 and increases the guanine nucleotide exchange activity of CHC1/RCC1. Recruits XPO1/CRM1 to CHC1/RCC1 in a Ran-dependent manner. Negative regulator of TGF- beta signaling through interaction with the R-SMAD proteins, SMAD2 and SMAD3, and mediating their nuclear export. {ECO:0000269|PubMed:11425870, ECO:0000269|PubMed:11571268, ECO:0000269|PubMed:11932251, ECO:0000269|PubMed:19289081, ECO:0000269|PubMed:9637251}. |Ran BP1| |R-SMAD binding| |Ran GTPase binding| |nuclear pore| |protein export from nucleus| |nuclear export| |nucleocytoplasmic transport| |nuclear transport| |GTPase activator activity| |positive regulation of GTPase activity| |regulation of GTPase activity| |positive regulation of hydrolase activity| |intracellular protein transport| |regulation of hydrolase activity| |positive regulation of catalytic activity| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |positive regulation of molecular function| |establishment of localization in cell| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-2.26| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.89| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.85| ^Gene^Correlation^ |[[:human genes:x:xpo1|XPO1]]|0.429| |[[:human genes:d:dip2b|DIP2B]]|0.409| |[[:human genes:m:med1|MED1]]|0.409| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1159 * **Expression level (log2 read counts)**: 6.27 {{:chemogenomics:nalm6 dist.png?nolink |}}